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SUMMARY KEYWORDS
Electroretinogram (ERG), widely used to
study the pharmacological effects of drugs in
animal models (e.g., diabetic retinopathy), is
usually recorded in anesthetized rats. We report
here a novel simple method to obtain chronic
implantation of electrodes for simultaneous
recording at the retinal and cortical levels in
freely moving, unanesthetized animals. We
recorded cortical (VEPs) and retinal (ERGs)
responses evoked by light (flash) stimuli in
awake rats and compared the results in the
same rats anesthetized with urethane (0.6
mg/kg) before and after the monocular admini-
stration of scopolamine methyl bromide (1%o
solution). We also compared the retinal
responses with those derived from a classic acute
corneal electrode. Anesthesia induced consistent
changes of several VEP and ERG parameters
like an increase of both latency and amplitude.
In particular, the analysis of the variation of
latency, amplitude, and spectral content of
rapid oscillatory potentials could be important
for a functional evaluation of the visual system
in unanesthetized versus anesthetized animals.
Reprint requests to: Alberto Loizzo, Istituto Superiore di
SanitY, Viale Regina Elena, 299, 00161, Roma-Italy. e-mail
alberto.loizzo@iss.it
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INTRODUCTION
Electroretinograms (ERGs), visual evoked
potentials (VEPs), and oscillatory potentials (OPs),
neurophysiologic methods that yield reproducible
results in routine clinical practice, provide an
objective functional measure of the visual path-
ways and related neural systems. These methods
have been studied in large groups of normal
subjects and in patients having a wide variety of
neurological, endocrine and dysmetabolic diseases.
Visual evoked potentials and ERGs are used for
diagnostic applications in the presence of
dysfunction in retinal layers and/or in the occipital
cortex (Parisi, 2001). Such techniques can also
provide a further therapeutic approach through the
possibility of monitoring neurophysiologic changes
related to diseases, to the alteration in the number
or concentration of neurotransmitters or drugs, or
to other situations that modulate the neuronal
response to external/internal stimulation.
Instead, OPs reflect short-term synchronization
of neuronal electrical activity. Oscillations around
the gamma range (40 to 100 Hz) reportedly play a
role in attention-related mechanisms and synaptic
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plasticity in cortical structures because they
promote coherence and possible ’binding’ of local
and neuronal activity (Adjamian, 2004; Babiloni,
2004; Tallon-Baudry, 2003). Animal studies have
been performed to confirm these hypotheses, in
which the efficacy of various pharmacological
agents or the differential impact of different
behavioral states can be tested thoroughly (Van
der Linden, 1999, Loizzo, 1998).
Although several studies have been published
on VEPs, very few experiments have been carried
out to study ERG parameters in awake rats (Szabo-
Salfay, 2001; Galambos, 1994)i In fact, such
studies generally refer to restrained (Boyes, 1983)
or anesthetized animals, with acute electrode
implants (Schaeppi, 1988; Shaw, 1998), but
anesthesia is known to affect electrophysiological
responses (Dyer, 1994; Rigdon, 1988; Hetzler,
1989; Porciatti, 1999). Therefore, here we describe
a new method to analyze the visual system of
freely moving, unanesthetized rats that provides a
model for simultaneously recording potentials at
both retinal and cortical levels. This technique has
been used in mice with optimal compliance
(Lopez, 2002; Loizzo, 2002). We performed a
comparison of retinal responses derived from this
new method with those obtained from a ’classic’
acute implant of electrodes, which is usually
performed in anesthetized animals, using surface
corneal electrodes. Furthermore, we verified the
effects of a cholinergic antagonist using quaternary
scopolamine because the structure of the molecule
prevents crossing through blood-brain barrier, thus
behaving as typical mydriatic agents used in
patients and experimental rats.
2. EXPERIMENTAL
2.1 Animals
Sprague Dawley rats (Charles River Italy,
Calco, Italy) (n=8) weighing 250 g each were
housed in a transparent plastic cage under standard
animal conditions with free access to food and
water, a 12 hrs light/dark cycle, and an ambient
temperature of 21 C. The animal care and use
followed the directives of the Council of the
European Communities. The Bioethical Committee
of the Italian National Institute of Health approved
the experimental protocol.
2.2 Surgery
Under xylazine (Rompun, Bayer AG,
Leverkusen-Germania, 20 mg/kg i.p.) and ketamine
(Ketavet 100, Gellini Farmaceutici Spa, Peschira
Borromea-MI, 32 mg/kg i.p.) and locally injected
lidocaine (Lidocaina 2%, Azienda Terapeutica
Italiana A.T.I. srl, Ozzano Emilia-BO, 0.1 ml s.c.)
anesthesia, the animals were c.hronically implanted,
the position of electrodes being determined with
reference to the sagittal suture and bregma. For
each animal, four L-shaped monopolar epidural
stainless-steel electrodes (0.8 mm diam./15 mm
length) were implanted on sensorimotor cortex for
VEPs recording: left and right posterior (5 mm
from the bregma and 4 mm lateral to the sagittal
suture bilaterally), right anterior (4 mm from the
bregma and 2 mm from the sagittal suture). To
assure stability to the dental cement implant on the
skull, we positioned a fourth electrode symmetrical
to the active one (left posterior, 1.5 mm caudal to
bregma). This electrode was not connected. For
flash ERGs recording two teflon coated tungsten
electrodes (0.2 mm diameter), covered with an
anallergic and insulating varnish, except for the tip
(0.5 mm), were applied: one was used as reference
and was inserted subcutaneously over the nasal
bone (1.5 cm long), and one behind the ocular
globe (7 mm long).
The position of ERG electrodes leaves the
retina just in the middle. The "active" electrode
was applied as to obtain a physical contact
between the electrode tip and the eye’s posterior
tunica, and is placed after drilling the left anteriorCHRONIC IMPLANT TO RECORD ERG, VEP AND OP IN AWAKE, FREELY MOVING RATS 243
Fig. 1 A. ERG active electrode; B. ERG reference
electrode; C. (D+) cortical electrode; D. (D-)
cortical electrode; E. Ground cortical electrode.
F. Support electrode, used only to enforce the
electrode structure embedded in dental cement
to the skull.
part of the skull (3 mm from the bregma and 2 mm
from the sagittal suture). The drill (always held in
the same hole) was inclined to leave of 35 degrees
on the frontal plane and of35 degrees on the sagittal
plane to perforate the orbital bone behind the lef
eye. The recording electrode was inserted for ~7
mm, so that the bare tip was in contact with the
posterior part of the eye. We could control the
position by gently pushing the electrode to induce a
reversible extroflession ofthe eye. The implant was
fixed with dental cement. During the surgery, a
heated table maintained the body temperature at 37
C. A recovery period of week was allowed before
the ERG and EEG recordings.
2.3 Stimuli
A Grass Instrument PS 22 photic stimulator
model supplied the flash stimulation. During the
recording, 90 successive light flashes (stimulus rate:
flash per second, duration: 10 ts) were presented.
Two intensities of stimulation, corresponding to
236.4 mcd/m2*s and 945.6 mcd/m2*s respectively,
were used. The stimulus intensity range was chosen
according to the results obtained in preliminary
sessions published elsewhere (Lopez, 2002)
2.4 Experimental protocol
The recording sessions, each lasting 120 min,
took place at the same time each morning to avoid
interferences due to circadian rhythm. Each rat
was recorded alone while housed in a cage with
mirrored walls, with the ceiling corresponding to
the flash stimulator positioned outside the sound-
proof cage to avoid acoustic interferences. First,
we recorded VEP and ERG in the awake, freely
moving rat. Then the same animal was anesthetized
with urethane (Sigma Chemical Co, Germany; 0.6
mg/kg) and VEP and ERG were recorded in both
conditions, i.e., through the chronic and the acute
implants. The latter consisted of a DTL electrode
(Bayer, 2001) positioned in the conjuntival sac and
recorded against a reference electrode inserted
subcutaneously over the nasal bone. The recording
procedure was repeated on the anesthetized
animal, after placing 50 tl of scopolamine
(scopolamine methyl bromide, 1% solution, Sigma
Chemical Co, Germany) on the left eye where the
ERG electrodes were positioned.
The EEG and ERG signals were amplified
through a DC powered preamplifier, with a.gain of
1000X and an analogic filter at Hz highpass
(HP) and a 500 Hz lowpass (LP) 6dB/octave. The
acquisition was performed at 2 kHz sampling rate.
An InstruNet A/D 16 bit conversion board
delivered the signals to the acquisition system
(Superscope- GW Instruments, Somerville, Massa-
chusetts, USA) on a personal computer (Macintosh
8150 Power PC) customized and adapted by
Analysa (Villafalletto CU, Italy). Brain and retinal
activity and trigger were continuously acquired
and saved as raw data to be analyzed off-line. The244 IRENE GUARINO ET AL
protocol of the experiment was the following: a
stimulation frequency of Hz was used for each
stimulation intensity, with a 10 rain interval
between each intensity level. The animals were not
scotopically adapted. Repetitions were performed
when more than 3 movement artifacts were visible
in the raw data. The amplitude and latency of the
VEP and the ERG responses were measured after
baseline normalization. The latency was calculated
as the absolute value between stimulus onset and
the peak of the first negative response, whereas
amplitude was taken both as an absolute value of
negative peak amplitude and as peak-to-peak value
between the first negative peak and the following
most prominent positive peak. Oscillatory potentials
(OPs) were extracted through the application of a
digital 50 Hz HP filter (linear phase FIR, 6 dB/
octave) to the raw data (Lopez, 2002). The latency
of the oscillation was measured in ms from the
trigger to the response peak. The amplitude was
calculated as the peak-to-peak value between the
first negative and the first positive peaks.
2.5 Statistical analysis
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The latencies and peak-to-peak amplitudes of
the major peaks of the evoked responses and of the
OPs were measured, and the differences between
pre- and post-treatment were compared in the same
animal. The differences in latency and peak-to-
peak amplitude were evaluated using Student’s t
test for paired data. When comparing the retinal
responses coming from chronic and acute implants,
Student’s test for the difference of the average
was used.
Fig. 2.1 A. Example of VEP in three differem conditions: in
awake (A), anaesthetized (U), and treated with scopol-
amine (S). Positive and negative peaks labeled as N 1,
P2, and N2 characterized baseline awake VEPs. B.
Superimposed on peaks, a train of higher frequency
positive and negative oscillatory potentials is labeled
as ONe, ON2, and OPt, OP2, respectively C. Power
spectrum ofcortical oscillatory potentials shown in B.
3. RESULTS
Figures 2.1, 2.2, and 2.3 contain illustrations
of different types of visual responses recorded in
the rat. We analyzed only P2 and OP2 for VEPs
and b2 and 02 peaks for ERGs because it has been
already shown that after anesthesia with urethane,
the cortical VEPs show a change in morphology
because of the disappearance of some negative
peaks (Dyer, 1994).CHRONIC IMPLANT TO RECORD ERG, VEP AND OP IN AWAKE, FREELY MOVING RATS 245
3.1 VEP parameters before and after urethane
and scopolamine
In awake rats, P2 appeared at a mean latency
of 46.5 + 1.8 (SEM) ms and an amplitude of 24.2
+ 6.3 ktV at the lower intensity of stimulation and
at a latency of 46.2 + 2.1 ms and an amplitude of
30.7 + 5.9 lxV at the higher intensity of stimulation.
Fig. 2.2 A. Example of ERG recorded in rat in three
different conditions: awake, anesthetized, and
treated with scopolamine rat. The ERG waveform
consists of an initial negative a- wave followed by
the slow- high amplitude b-waves (identified as
b 1, b2, and b3). B. Superimposed on this potential
there is a train of high positive and negative
frequencies (O1, 02, 03. and O.land 0.2
respectively). C. Power spectann of retinal
oscillatory potentials shown in B.
After anesthesia it showed a consistent increase of
latency (62.9 + 2.3 ms and 58.8+/- 1.7 ms at the lower
and higher intensities of stimulation, in both cases
P < 0.01) (Fig. 3) and amplitude (66.2 +/- 11.2
and 88.7 + 11..9 l.tV respectively, P<0.01) (Fig. 4).
The same trend of latency was observed after
treatment with scopolamine methyl bromide (68.3 +
3.6 ms P<0.05 at lower and 61.3 + 2.7 ms P<0.05 at
higher intensity of stimulation) (Fig. 3). The ampli-
tude was lower then after anesthesia; this decrement
was significant only at the higher intensity (88.7 +
11.9ttV vs 44.4 + 13.2 IxV, P<0.01) (Fig. 4).
The peak OP2 showed a latency range between
38 and 43 ms at stronger intensity of stimulation in
awake animals. Latency to intensity relationship
curves displayed a very similar trend to VEPs, but
amplitude decreased after anesthesia with urethane,
especially at the lower intensity (8.1 +/- 0.9 tV vs
2.1 +/- 0.2 tV, P<0.01). The latency of OP2
increased after scopolamine (55.7 + 0.7 ms vs 63.6
+/- 2.0 ms and 53.1+ 1.9 ms vs 59.3 + 2.9 ms at both
intensities considered, P<0.05) (Fig. 3), while
amplitude decreased (2.1 + 0.2 laV vs 1.3 _+ 0.2 tV
and 2.6+ 0.51.tV vs 1.3 + 0.2tV; P<0.05) (Fig. 4).
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Fig. 2.3 Example of ERG recorded using the DTL acute
electrode alter both urethane and scopolamine246 IRENE GUARINO ET AL
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Latency mean of the different peaks (P2, OP2, b2 and 02) evaluated in awake rat and atter treatment with urethane and
scopolamine. Data are elicited by the lower intensities of luminous stimulation (236.4 mcd/m2*s). Symbols indicate:
P<0.05; ** P< 0.01; Y=awake vs urethane; Z= urethane vs scopolamine; X= awake vs scopolamine.
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Fig. 4 Amplitude mean of P2 (A) and OP2 (B) peaks evaluated in awake (A) and after treatment with urethane (U) and scopolamine (S)
rats. Data are elicited by the higher intensities ofluminous stimulation (945.6 cd/m2*s). Symbols indicate: * P<0.05; ** P< 0.01;
Y=awake vs urethane; Z urethane vs scopolamine; X awake vs scopolamine.CHRONIC IMPLANT TO RECORD ERG, VEP AND OP IN AWAKE, FREELY MOVING RATS 247
3.2 ERG parameters before and after urethane
and scopolamine
In awake animals, b2 showed a latency of 37.8
+ ms at the lower intensity and a latency of 35.5 +
1.0 ms at the higher intensity of stimulation. After
anesthesia we observed a significant (P<0.05)
increase of latency at lower intensity of stimulation
(41.9 + 1.6 ms) and no significant variation of
amplitude. The same trend was observed for the 02
wave (Fig. 3) especially after use of scopolamine
methyl bromide (41.1 + 1.3. ms. vs 47.8 + 1.6 ms at
lower intensity; P<0.05), these differences, however
were not consistent after urethane. The b2 latency
variations between electrical responses coming from
chronic and acute electrodes were not observed, as
expected. On the contrary, the amplitude of the
same peak was different, especially at the higher
intensity (14.6 + 6.2 tV vs 47.4 + 7.4 tV
respectively, P<0.01).
Comparing electrical responses coming from
chronic and acute retinal electrodes a significant
increase of response amplitude recorded from
acute electrodes was also observed after using
100 A B
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Fig. 5: Difference of b2 peak amplitude between chronic
(eh) and acute (ac) implants after treatment with (A)
urethane and (B) urethane + scopolamine.
** indicates P<0.01.
scopolamine, especially at the higher intensity (28
+ 10 tV vs 62.6 + 16 tV; P<0.01) (Fig 5).
Our experiment was based on the analysis of
VEP, ERG, and OP (cortical and retinal) recorded
under three different conditions: awake rats,
anesthetized rats, and anesthetized rats topically
treated with scopolamine methyl bromide. To
obtain this experimental model on awake rats, it
was first necessary to develop a method for a
chronic retinal electrode implant similar to the one
previously applied on mice (Lopez, 2002; Loizzo,
2002), on conscious dogs (Sato, 1982), and on
monkeys or micropigs (Heynen, 1985; Rosolen,
1999). In particular, ERGs coming from the
chronic implant were compared with those recorded
from a classic acute one. In fact, the evoked
responses from retina are usually recorded in
anesthetized animals, but different anesthetics are
known to affect the electrophysiological responses
of the animal differently (Brown, 1984; Raitta,
1979; Vaegan, 1990). In our experimental
conditions, urethane produced qualitative and
quantitative alterations in the rat’s VEPs.
Qualitatively, the dominant effect was the abolition
of the N1 peak, already observed by Dyer (1994);
quantitatively, we observed a latency increase of
the P2, OP2, b2, and 02 peaks, a consistent
amplitude increase of the P2 peak, and an
amplitude decrease of the OP2 peak. The latency
increase, a characteristic of many anesthetics, is
due to a depression of conduction in the visual
pathways. This effect is not unique to urethane. In
general, substances that appear to increase
GABAergic inhibition tend to increase the
amplitude of the second positive peak evoked in
cats by step increments in luminance, whereas
substances that tend to decrease GABAergic
inhibition tend to decrease the amplitude of this
peak (Zemon, 1986).
The use of a digital 50 Hz HP filter was
followed by a strong abatement of high
frequencies in the spectrum of PEV and therefore
of OPs (Fig. 4B). We cannot explain why urethane248 IRENE GUARINO ET AL
treatment is followed by an increase in P2 peak
amplitude. One hypothesis is that the drug, which
induces a diminution of high frequencies, induces
as well a certain shift of frequency power toward
lower frequencies.
When we compared the ERG coming from
chronic and acute implants, we observed that b2 of
the acute implant showed a significant amplitude
increase versus the responses coming from the
chronic implant. The same trend was observed
after local treatment with scopolamine methyl
bromide. In the chronic implant, the electrode is
positioned behind the ocular globe, and the
insulating electric properties of sclera can interfere
with the electric transmission of the signal, thus
inducing a lower amplitude signal.
After using scopolamine methyl bromide, we
also observed a further increase in the latency of
the P2, OP2, b2, and O2 peaks and a decrease in the
amplitude of the P2 and OPt_ peaks. In the
literature, few and controversial data about scopol-
amine action on eye have been reported. Arakawa
et al. (1997) found that in the anesthetized cat,
scopolamine (0.7 mg/kg i.v.) increases the
amplitude of the responses to ketamine and 1%
halothane recorded from the primary visual cortex.
Sannita et al. (1993, 1988), by contrast, showed
that in conscious humans, scopolamine (0.25, 0.50,
and 0.75 mg/kg i.m.) reduces the amplitude of the
late components of the flash-evoked potential
without affecting latency. In addition, Harding
(1994) investigated the action of a topical
administration of 0.125 % scopolamine applied
monocularly and found no change in latency
between the control and experimental and after
administering scopolamine.
Our results suggest that this drug could alter
not only the amplitude but also and especially the
latency of electrical responses, so we suggest that
antimuscarinic drugs applied as mydriatics during
neurophysiologic experiments can induce variation
in the retinal response, even if the drug hardly
passes the blood brain barrier, as in the case of
methyl bromide scopolamine. As our’ target was to
compare retinal responses coming from chronic
and acute implants in the same animals during the
same experimental session, we did not perform a
comparison between anesthetized and awake
animals treated with scopolamine.
From the results of this study, we conclude
that the use of the retinal chronic implant allows
the recording of visual-evoked responses in awake
animals, unrestrained, avoiding physiological
changes coming from anesthesia, and possible
interactions between the anesthetic and other
drugs, which becomes essential when studying
drugs acting on retinal pathophysiology. In
conclusion, anesthesia in general induced a
consistent increase of latency in both VEP and
ERG, and an increase in the latency of the
oscillatory potentials ofVEP and ERG. Anesthesia
also induced an increase in VEP amplitude,
whereas no consistent differences were recorded
for ERG. The oscillatory potentials of VEP were
consistently reduced, whereas we could not gather
enough data for ERG. An increase in the
amplitude of potentials, however, accompanied by
a reduction in the decrease of OPs amplitude
induced by anesthesia, would indicate a shift of
spectral content toward lower bands.
Oscillatory potentials latency and amplitude
might be of particular importance in the evaluation
of retinal damage and/or changes in neural
plasticity induced by experimental (e.g. diabetes)
conditions. Oscillatory potentials features can be
also modulated during different behavioral states.
Therefore, the use of chronic implants that allow
recording the high-frequency spectral content of
electric responses in awake, freely moving animals
can be of help in the evaluation of retinal damage
and of the protective effect of drugs (Yu, 1998).
This kind of implant persists on site 30 to 45 days
and can allow studies on neural/retinal conditions,
evolution, and possible pharmacological treatment.CHRONIC IMPLANT TO RECORD ERG, VEP AND OP IN AWAKE, FREELY MOVING RATS 249
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